Yoseph Shaaltiel
2016
In 2016, Yoseph Shaaltiel earned a total compensation of $465.1K as Executive Vice President, Research and Development at Protalix BioTherapeutics, a 29% decrease compared to previous year.
Compensation breakdown
| Option Awards | $103,279 |
|---|---|
| Salary | $270,248 |
| Stock Awards | $18,211 |
| Other | $73,325 |
| Total | $465,063 |
Shaaltiel received $270.2K in salary, accounting for 58% of the total pay in 2016.
Shaaltiel also received $103.3K in option awards, $18.2K in stock awards and $73.3K in other compensation.
Rankings
In 2016, Yoseph Shaaltiel's compensation ranked 11,428th out of 14,075 executives tracked by ExecPay. In other words, Shaaltiel earned more than 18.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,428 out of 14,075 | 19th |
Division Manufacturing | 4,455 out of 5,489 | 19th |
Major group Chemicals And Allied Products | 1,598 out of 1,895 | 16th |
Industry group Drugs | 1,293 out of 1,538 | 16th |
Industry Biological Products, Except Diagnostic Substances | 229 out of 279 | 18th |
Source: SEC filing on March 16, 2017.
Shaaltiel's colleagues
We found four more compensation records of executives who worked with Yoseph Shaaltiel at Protalix BioTherapeutics in 2016.